Does the relief of glucose toxicity act as a mediator in proliferative actions of vanadium on pancreatic islet beta cells in streptozocin diabetic rats?

Iranian Biomedical Journal

Volumn 18, Issue 3, 2014, Pages 173-180

  Pirmoradi, Leila ^a   Mohammadi, Mohammad Taghi ^a   Safaei, Akbar ^a   Mesbah, Fakhardin ^a   Dehghani, Gholam Abbas ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Beta cells; Diabetes; Protection; Rats; Vanadium

Indexed keywords

ISOPHANE INSULIN; STREPTOZOCIN; VANADIUM; GLUCOSE; GLUCOSE BLOOD LEVEL; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DRUG RESPONSE; GLUCOSE BLOOD LEVEL; GLUCOTOXICITY; HISTOLOGY; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; BLOOD; BODY WEIGHT; DRINKING BEHAVIOR; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DRINKING BEHAVIOR; GLUCOSE; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; MALE; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; VANADIUM;

EID: 84901496791     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: 10.6091/ibj.1329.2014     Document Type: Article

References (31)

1. Weir GC, Bonner-Weir S. Islet beta cell mass in diabetes and how it relates to function, birth, and death. Ann N Y Acad Sci. 2013 Apr; 1281:92-105.
2. Jonas JC, Bensellam M, Duprez J, Elouil H, Guiot Y, Pascal SM. Glucose regulation of islet stress responses and beta-cell failure in type 2 diabetes. Diabetes Obes Metab. 2009 Nov; 11 Suppl 4:65-81.
3. Yeo RWY, Yang K, Li G, Lim SK. High glucose predisposes gene expression and ERK phosphorylation to apoptosis and impaired glucose-stimulated insulin secretion via the cytoskeleton. PLoS ONE. 2012 Sep. 7(9):e44988
4. Wajchenberg BL. Beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev. 2007 April; 28(2):187-218.
5. Heyliger CE, Tahiliani AG, McNeill JH. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science. 1985 Mar; 227(4693):1474-7.
6. Thulesen J, Orskov C, Holst JJ, Poulsen SS. Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats. Endocrinology. 1997 Jan; 138(1): 62-8.
7. Inoue K, Cetkovic-Cvrlje M, Eizirik DL, Grill V. Irreversible loss of normal beta-cell regulation by glucose in neonatally streptozotocin diabetic rats. Diabetologia. 1994. 37(4):351-7.
8. Dehghani GA, Atapour N, Sotoodeh M, Omrani GR. The influence of vanadyl sulphate on islet cells, blood glucose and insulin levels of normal and STZ-induced diabetic rats. Iran J Med Sci. 1992; 17(3-4):167-72.
9. Yanardag R, Tunali S. Vanadyl sulfate administration protects the streptozotocin-induced oxidative damage to brain tissue in rats. Mol Cell Biochem. 2006 Jun; 286(1-2):153-9.
10. Ahmadi S, Karimian SM, Sotoudeh M, Bahadori M, Dehghani GA. Pancreatic islet beta cell protective effect of oral vanadyl sulphate in streptozotocin-induced diabetic rats, an ultrastructure study. Pak J Biol Sci. 2010 Dec; 13(23):1135-40.
11. Ramanadham S, Mongold JJ, Brownsey RW, Cros GH, McNeill JH. Oral vanadyl sulfate in treatment of diabetes mellitus in rats. Am J Physiol. 1989 Sep; 257(3 Pt 2):H904-11.
12. Dehghani GA, Ahmadi S, Omrani GR. Effects of vanadyl sulphate on glucose homeostasis in severe diabetes induced by streptozotocin in rats. Indian J Med Res. 1997 Nov; 106:481-5.
13. Pederson RA, Ramanadham S, Buchan AM, McNeill JH. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats. Diabetes. 1989 Nov; 38(11):1390-5.
14. Dehghani GA, Atapour N, Sotoodeh M, Omrani GR. Trophic effects of vanadyl sulphate on islet cells, blood glucose, and insulin levels of normal and STZinduced diabetic rats. Iran J Med Sci. 1994. 13:167-73.
15. Dehghani GA, Sotoodeh M, Omrani GR. Trophic effects of vanadium on beta-cells of STZ-induced insulin dependent diabetic rats & evidence for long-term relief of diabetes mellitus. Indian J Med Res. 1999; 110: 70-5.
16. Bolkent S, Bolkent S, Yanardag R, Tunali S. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats. Diabetes Res Clin Pract. 2005 Nov; 70(2):103-9.
17. Clark TA, Heyliger CE, Kopilas M, Edel AL, Junaid A, Aguilar F, et al. A tea/vanadate decoction delivered orally over 14 months to diabetic rats induces long-term glycemic stability without organ toxicity. Metabolism. 2012 May; 61(5):742-53
18. Cam MC, Li WM, McNeill JH. Partial preservation of pancreatic β-cells by vanadium: evidence for long-term amelioration of diabetes. Metabolism. 1997 Jul; 46(7):769-78.
19. Zini E, Osto M, Franchini M, Guscetti F, Donath MY, Perren A, et al. Reusch CE. Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat. Diabetologia. 2009 Feb; 52(2):336-46.
20. Cam MC, Pederson RA, Brownsey RW, McNeill JH. Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats. Diabetologia. 1993 MAr; 36(3):218-24.
21. Yanardag R, Demirci TB, Ülküseven B, Bolkent S, Tunali S. Synthesis, characterization and antidiabetic properties of N1-2,4-dihydroxybenzylidene-N4-2-hydroxybenzylidene-S-methyl-thiosemicar bazidato-oxovanadium(IV). Eur J Med Chem. 2009; 44(2):818-26.
22. Cam MC, Rodrigues B, McNeill JH. Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes. Eur J Endocrinol. 1999 Nov; 141(5):546-54.
23. Thorens B. Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes Metab. 2011; 13 Suppl 1:82-8.
24. Marty N, Dallaporta M, Thorens B. Brain glucose sensing, counterregulation, and energy homeostasis. Physiology (Bethesda). 2007 Aug; 22:241-51.
25. Chiaraviglio E, Lozada C. Effect of intracerebroventricular vanadate administration on salt and water intake and excretion in the rat. Pharmacol Biochem Behav. 1986 Jun; 24(6):1503-8.
26. Xie MJ, Yang XD, Liu WP, Yan SP, Meng ZH. Insulinenhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity. J Inorg Biochem. 2010 Aug; 104(8):851-7.
27. Cam MC, Brownsey RW, McNeill JH. Mechanisms of vanadium action: Insulin-mimetic or insulin-enhancing agent? Can J Physiol Pharmacol. 2000 Oct; 78(10):829-47.
28. McNeill JH, Battell M, Cam M, Dai S, Thompson K, Yuen V. Oral vanadium and lowering of blood glucose. Diabetes. 1994; 43(10):1268-70.
29. Soveid M, Dehghani GA, Omrani GR. Long-term efficacy and safety of vanadium in the treatment of type 1 diabetes. Arch Iran Med. 2013 Jul; 16(7):408-11.
30. Ksiazek K, Breborowicz A, Jorres A, Witowski J. Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose. Free Radic Biol Med. 2007 Mar; 42(5):636-41.
31. Donath MY, Gross DJ, Cerasi E, Kaiser N. Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes. 1999 Apr; 48(4):738-44.